Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (1-10 of 383) with videos related to

Pageof 39
Sort By:
Steroids|March 8, 2011
Pharmacology of arthralgia with estrogen deprivationAnneleen Lintermans, Patrick Neven
Expert Opinion on Drug Safety|June 11, 2015
Safety of aromatase inhibitor therapy in breast cancerAnneleen Lintermans, Patrick Neven
Maturitas|September 19, 2009
Circulating estradiol and tumor phenotype in postmenopausal breast cancer patientsHyonil Cho, Patrick Neven
Maturitas|June 18, 2002
Endometrial safety of hormone replacement therapy: review of literatureToon Van Gorp, Patrick Neven
Nature Reviews. Clinical Oncology|July 22, 2025
PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER<sup>+</sup>HER2<sup>-</sup> breast cancer harbouring acquired ESR1 mutationsPatrick Neven, Sileny N Han
Expert Opinion on Drug Safety|March 25, 2011
Drug safety evaluation of exemestaneAnneleen Lintermans, Patrick Neven, Robert Paridaens
The Lancet. Oncology|July 20, 2010
Laparoscopic hysterectomy for early endometrial cancerIgnace Vergote, Frederic Amant, Patrick Neven
The New England Journal of Medicine|February 17, 2012
Adjuvant trastuzumab in HER2-positive breast cancerJoke Vanderhaegen, Robert Paridaens, Patrick Neven
The Lancet. Oncology|July 12, 2016
Combined modality adjuvant therapy for high-risk endometrial cancerAdriaan Vanderstichele, Patrick Neven, Ignace Vergote
Breast Cancer Research : BCR|October 13, 2016
Extending the Developmental Origins of Health and Disease theory: does paternal diet contribute to breast cancer risk in daughters?Stephanie Romanus, Patrick Neven, Adelheid Soubry
Pageof 39

Showing results (1-10 of 383) with videos related to

Sort By:
Pageof 39
Steroids|March 8, 2011
Pharmacology of arthralgia with estrogen deprivationAnneleen Lintermans, Patrick Neven
Expert Opinion on Drug Safety|June 11, 2015
Safety of aromatase inhibitor therapy in breast cancerAnneleen Lintermans, Patrick Neven
Maturitas|September 19, 2009
Circulating estradiol and tumor phenotype in postmenopausal breast cancer patientsHyonil Cho, Patrick Neven
Maturitas|June 18, 2002
Endometrial safety of hormone replacement therapy: review of literatureToon Van Gorp, Patrick Neven
Nature Reviews. Clinical Oncology|July 22, 2025
PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER<sup>+</sup>HER2<sup>-</sup> breast cancer harbouring acquired ESR1 mutationsPatrick Neven, Sileny N Han
Expert Opinion on Drug Safety|March 25, 2011
Drug safety evaluation of exemestaneAnneleen Lintermans, Patrick Neven, Robert Paridaens
The Lancet. Oncology|July 20, 2010
Laparoscopic hysterectomy for early endometrial cancerIgnace Vergote, Frederic Amant, Patrick Neven
The New England Journal of Medicine|February 17, 2012
Adjuvant trastuzumab in HER2-positive breast cancerJoke Vanderhaegen, Robert Paridaens, Patrick Neven
The Lancet. Oncology|July 12, 2016
Combined modality adjuvant therapy for high-risk endometrial cancerAdriaan Vanderstichele, Patrick Neven, Ignace Vergote
Breast Cancer Research : BCR|October 13, 2016
Extending the Developmental Origins of Health and Disease theory: does paternal diet contribute to breast cancer risk in daughters?Stephanie Romanus, Patrick Neven, Adelheid Soubry
Pageof 39